Current Data Regarding the Relationship between Type 2 Diabetes Mellitus and Cardiovascular Risk Factors
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Current Data Regarding the Relationship between Type 2 Diabetes Mellitus and Cardiovascular Risk Factors
Authors
Keywords
-
Journal
Diagnostics
Volume 10, Issue 5, Pages 314
Publisher
MDPI AG
Online
2020-05-18
DOI
10.3390/diagnostics10050314
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Acute Coronary Syndromes in Chronic Kidney Disease: Clinical and Therapeutic Characteristics
- (2020) Mădălina Ioana Moisi et al. Medicina-Lithuania
- Diabetic nephropathy: recent advances in pathophysiology and challenges in dietary management
- (2019) Mahaboob Khan Sulaiman Diabetology & Metabolic Syndrome
- Emerging Role of SGLT-2 Inhibitors for the Treatment of Obesity
- (2019) Maria J. Pereira et al. DRUGS
- Current Trends in Non-HDL-Cholesterol and LDL-Cholesterol Levels in Adults with Atherosclerotic Cardiovascular Disease
- (2019) Gloria Lena Vega et al. Journal of Clinical Lipidology
- SGLT2 inhibitors in patients with type 2 diabetes and renal disease: overview of current evidence
- (2019) Jaime A Davidson POSTGRADUATE MEDICINE
- Applications of Antioxidants in Metabolic Disorders and Degenerative Diseases: Mechanistic Approach
- (2019) Mohamed M. Abdel-Daim et al. Oxidative Medicine and Cellular Longevity
- 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk
- (2019) François Mach et al. EUROPEAN HEART JOURNAL
- Effects of sodium glucose co-transporter 2 inhibitors on the kidney
- (2018) Natalia de Albuquerque Rocha et al. Diabetes & Vascular Disease Research
- CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM – 2018 EXECUTIVE SUMMARY
- (2018) Alan J. Garber et al. Endocrine Practice
- GLP-1 Receptor Agonists and Cardiovascular Disease in Patients with Type 2 Diabetes
- (2018) María Isabel del Olmo-Garcia et al. Journal of Diabetes Research
- Serum Non-High-Density Lipoprotein Cholesterol and Risk of Cardiovascular Disease in Community Dwellers with Chronic Kidney Disease: the Hisayama Study
- (2017) Tomoko Usui et al. Journal of Atherosclerosis and Thrombosis
- Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
- (2017) Bruce Neal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Metformin: a review of its potential indications
- (2017) Yi-Wei Wang et al. Drug Design Development and Therapy
- Hypoglycemia and Cardiovascular Risk: Is There a Major Link?
- (2016) Markolf Hanefeld et al. DIABETES CARE
- Introduction
- (2016) DIABETES CARE
- Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Triglycerides to high-density lipoprotein–cholesterol ratio, glycemic control and cardiovascular risk in obese patients with type 2 diabetes
- (2016) Renato Quispe et al. Current Opinion in Endocrinology Diabetes and Obesity
- An update on sodium-glucose co-transporter-2 inhibitors for the treatment of diabetes mellitus
- (2016) Daniel S. Hsia et al. Current Opinion in Endocrinology Diabetes and Obesity
- Diabetes Dyslipidemia
- (2016) Jonathan D. Schofield et al. Diabetes Therapy
- Diabetes Dyslipidemia
- (2016) Jonathan D. Schofield et al. Diabetes Therapy
- Benefits and Harms of Sodium-Glucose Co-Transporter 2 Inhibitors in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis
- (2016) Heidi Storgaard et al. PLoS One
- New insights into the pathophysiology of dyslipidemia in type 2 diabetes
- (2015) Marja-Riitta Taskinen et al. ATHEROSCLEROSIS
- Effect of Glucagon-like Peptide-1 Receptor Agonists on Lipid Profiles Among Type 2 Diabetes: A Systematic Review and Network Meta-analysis
- (2015) Feng Sun et al. CLINICAL THERAPEUTICS
- Impact of GLP-1 receptor agonists on blood pressure, heart rate and hypertension among patients with type 2 diabetes: A systematic review and network meta-analysis
- (2015) Feng Sun et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Pathophysiology of diabetic dyslipidaemia: where are we?
- (2015) Bruno Vergès DIABETOLOGIA
- Effect of lifestyle intervention in patients with type 2 diabetes: A meta-analysis
- (2015) Liang Chen et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
- (2015) Bernard Zinman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Metformin and Inflammation: Its Potential Beyond Glucose-lowering Effect
- (2015) Yoshifumi Saisho Endocrine Metabolic & Immune Disorders-Drug Targets
- Diabetic Nephropathy and CKD—Analysis of Individual Patient Serum Creatinine Trajectories: A Forgotten Diagnostic Methodology for Diabetic CKD Prognostication and Prediction
- (2015) Macaulay Onuigbo et al. Journal of Clinical Medicine
- Agreement between Framingham Risk Score and United Kingdom Prospective Diabetes Study Risk Engine in Identifying High Coronary Heart Disease Risk in North Indian Population
- (2015) Dipika Bansal et al. Diabetes & Metabolism Journal
- Change in cardiovascular risk factors following early diagnosis of type 2 diabetes: a cohort analysis of a cluster-randomised trial
- (2014) James A Black et al. BRITISH JOURNAL OF GENERAL PRACTICE
- Coronary Artery Disease and Diabetes Mellitus
- (2014) Doron Aronson et al. CARDIOLOGY CLINICS
- Cardiovascular effects of Glucagon-like peptide 1 (GLP-1) receptor agonists
- (2014) Francisco Kerr Saraiva et al. Cardiovascular Diabetology
- Efficacy and Safety of Dulaglutide Monotherapy Versus Metformin in Type 2 Diabetes in a Randomized Controlled Trial (AWARD-3)
- (2014) Guillermo Umpierrez et al. DIABETES CARE
- Comparison of the Framingham Risk Score, UK Prospective Diabetes Study (UKPDS) Risk Engine, Japanese Atherosclerosis Longitudinal Study-Existing Cohorts Combine (JALS-ECC) and Maximum Carotid Intima-Media Thickness for Predicting Coronary Artery Stenosis in Patients with Asymptomatic Type 2 Diabetes
- (2014) Kazuya Fujihara et al. Journal of Atherosclerosis and Thrombosis
- Effects of blood pressure lowering on outcome incidence in hypertension. 1. Overview, meta-analyses, and meta-regression analyses of randomized trials
- (2014) Costas Thomopoulos et al. JOURNAL OF HYPERTENSION
- Importance of cardiovascular disease risk management in patients with type 2 diabetes mellitus
- (2014) Daniel Lorber Diabetes Metabolic Syndrome and Obesity-Targets and Therapy
- A Comprehensive Review on Metabolic Syndrome
- (2014) Jaspinder Kaur Cardiology Research and Practice
- Comparative Effectiveness and Safety of Medications for Type 2 Diabetes: An Update Including New Drugs and 2-Drug Combinations
- (2013) Wendy L. Bennett et al. ANNALS OF INTERNAL MEDICINE
- Comparative performance of diabetes-specific and general population-based cardiovascular risk assessment models in people with diabetes mellitus
- (2013) J.-B. Echouffo-Tcheugui et al. DIABETES & METABOLISM
- Diabetes and Nonalcoholic Fatty Liver Disease: A Pathogenic Duo
- (2013) K. H. Williams et al. ENDOCRINE REVIEWS
- Insulin Resistance as a Predictor of Cardiovascular Disease in Patients on Peritoneal Dialysis
- (2013) Y. Li et al. PERITONEAL DIALYSIS INTERNATIONAL
- Metabolic syndrome as a predictor of type 2 diabetes, and its clinical interpretations and usefulness
- (2013) Jeong-Ah Shin et al. Journal of Diabetes Investigation
- Impact of Diabetes on Cardiovascular Disease: An Update
- (2013) Alessandra Saldanha de Mattos Matheus et al. International Journal of Hypertension
- Insulin Resistance in Patients with Chronic Kidney Disease
- (2012) Min-Tser Liao et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- A GLP-1 receptor agonist liraglutide inhibits endothelial cell dysfunction and vascular adhesion molecule expression in an ApoE-/- mouse model
- (2011) Tracey Gaspari et al. Diabetes & Vascular Disease Research
- Insulin resistance and left ventricular hypertrophy in end-stage renal disease: association between the ENPP1 gene and left ventricular concentric remodelling
- (2011) B. Spoto et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- DURATION-1: Exenatide Once Weekly Produces Sustained Glycemic Control and Weight Loss Over 52 Weeks
- (2010) J. B. Buse et al. DIABETES CARE
- Effect of metformin on oxidative stress, nitrosative stress and inflammatory biomarkers in type 2 diabetes patients
- (2010) Arpita Chakraborty et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Achieving lipid targets in adults with type 2 diabetes: The Stop Atherosclerosis in Native Diabetics Study
- (2010) Marie Russell et al. Journal of Clinical Lipidology
- Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
- Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
- Effects of Exenatide on Systolic Blood Pressure in Subjects With Type 2 Diabetes
- (2009) T. Okerson et al. AMERICAN JOURNAL OF HYPERTENSION
- A comprehensive definition for metabolic syndrome
- (2009) P. L. Huang Disease Models & Mechanisms
- Lipid modification in type 2 diabetes: the role of LDL and HDL
- (2009) Bruno Vergès FUNDAMENTAL & CLINICAL PHARMACOLOGY
- Major Lipids, Apolipoproteins, and Risk of Vascular Disease
- (2009) The Emerging Risk Factors Collaboration* JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Meta-Analysis of the Relationship Between Non–High-Density Lipoprotein Cholesterol Reduction and Coronary Heart Disease Risk
- (2009) Jennifer G. Robinson et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6)
- (2009) John B Buse et al. LANCET
- Performance of the UK Prospective Diabetes Study Risk Engine and the Framingham Risk Equations in Estimating Cardiovascular Disease in the EPIC- Norfolk Cohort
- (2008) R. K. Simmons et al. DIABETES CARE
- Effects of Fenofibrate Treatment on Cardiovascular Disease Risk in 9,795 Individuals With Type 2 Diabetes and Various Components of the Metabolic Syndrome: The Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study
- (2008) R. Scott et al. DIABETES CARE
- Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials: A position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association
- (2008) J. S. Skyler et al. DIABETES CARE
- The Metabolic Syndrome
- (2008) Marc-Andre Cornier et al. ENDOCRINE REVIEWS
- Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes
- (2008) NEW ENGLAND JOURNAL OF MEDICINE
- Effects of Intensive Glucose Lowering in Type 2 Diabetes
- (2008) NEW ENGLAND JOURNAL OF MEDICINE
- 10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes
- (2008) Rury R. Holman et al. NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More